계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
E-nitiate Biopharmaceuticals
company
About
E-nitiate Biopharmaceuticals is committed to the development of innovative drugs for autoimmune diseases, through independent research.
- 1 - 10
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- ¥100M
- Industries
- Biopharma,Biotechnology,Health Care,Hospital
- Founded date
- Jan 1, 2020
- Number Of Employee
- 1 - 10
- Operating Status
- Active
E-nitiate Biopharmaceuticals is committed to the development of innovative drugs for autoimmune diseases, through independent research and development, and strategic collaborations, to address unmet medical needs and to improve the quality of human life.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
¥100M
E-nitiate Biopharmaceuticals has raised a total of
¥100M
in funding over 2 rounds. Their latest funding was raised on
Sep 15, 2022 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 15, 2022 | Series A | ¥100M | 4 |
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
4
E-nitiate Biopharmaceuticals is funded by 4 investors.
Momentum Venture
and TaiKun Fund
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Series A |
|
|
— | Series A |
|
|
— | Series A |
|
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
